| Absorption |
| Blood-Brain Barrier | BBB- | 0.9309 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2- | 0.8319 |
| P-glycoprotein Substrate | Substrate | 0.5440 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9311 |
| Non-inhibitor | 0.8529 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8927 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6898 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7447 |
| CYP450 2D6 Substrate | Non-substrate | 0.8921 |
| CYP450 3A4 Substrate | Non-substrate | 0.6409 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7060 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9305 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9255 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8565 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7788 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9174 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7396 |
| Non-inhibitor | 0.7962 |
| AMES Toxicity | Non AMES toxic | 0.8487 |
| Carcinogens | Non-carcinogens | 0.8836 |
| Fish Toxicity | Low FHMT | 0.5172 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7578 |
| Honey Bee Toxicity | Low HBT | 0.6310 |
| Biodegradation | Not ready biodegradable | 0.6453 |
| Acute Oral Toxicity | II | 0.4734 |
| Carcinogenicity (Three-class) | Non-required | 0.7160 |